Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

P. Rutgeerts*, G. D'Haens, S. Targan, E. Vasiliauskas, S. B. Hanauer, D. H. Present, L. Mayer, R. A. Van Hogezand, T. Braakman, K. L. DeWoody, T. F. Schaible, S. J H Van Deventer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1033 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences